Format

Send to

Choose Destination
Expert Rev Anticancer Ther. 2017 Aug;17(8):687-692. doi: 10.1080/14737140.2017.1335199. Epub 2017 Jun 5.

Anticancer treatments and female fertility: clinical concerns and role of oncologists in oncofertility practice.

Author information

1
a Department of Obstetrics and Gynecology, Medical Faculty , University of Cologne , Cologne , Germany.
2
b Department of Obstetrics and Gynecology, Feinberg School of Medicine , Northwestern University , Chicago , Illinois , USA.

Abstract

Anticancer treatments such as aggressive chemotherapy and radiotherapy have deleterious gonadotoxic side effects and are considered the most common causes of pathological and iatrogenic fertility loss in women. Areas covered: In order to preserve fertility of young women and girls with cancer, several established, experimental, and debatable options can be offered in the emerging field of oncofertility. This article reviews the effects of anticancer treatments on female fertility and discusses the current challenges and future directions of fertility preservation options that can be offered to the female patients with cancer. Expert commentary: Although promising, several medical, economic, social and legal barriers face oncofertility practice around the globe especially in underserved areas. To overcome such barriers, more effective solutions should be provided to spread awareness and enhance communication between patients, oncologists and gynecologists. Early referral by oncologists before initiation of chemotherapy and radiotherapy is an important key factor for success in female fertility preservation strategies.

KEYWORDS:

Anticancer treatments; female fertility loss; female fertility preservation; gonadotoxicity; oncofertility

PMID:
28537815
PMCID:
PMC6145143
DOI:
10.1080/14737140.2017.1335199
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center